Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NASDAQ, INC. (NDAQ)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 5
  • 1 comments

Nasdaq Halts Happy City Holdings Ltd

Market reaction Comment Full text

ASIA PROPERTIES, INC. (HYOR)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 4
  • 1 comments

HyOrc Corporation Profiled by Lux Research, Validating Disruptive Green Methanol Production Economics

Market reaction Comment Full text

MASCO CORP /DE/ (MAS)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 2
  • 1 comments

Masco Corporation Announces Date for Earnings Release and Conference Call for 2026 Second Quarter

Market reaction Comment Full text

ESTABLISHMENT LABS HOLDINGS INC. (ESTA)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 4
  • 1 comments

Establishment Labs® Appoints Taylor Harris to Board of Directors

Market reaction Comment Full text

VIRTUS DIVERSIFIED INCOME & CONVERTIBLE FUND (ZTR)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 3
  • 1 comments

Virtus Total Return Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice

Market reaction Comment Full text

RANI THERAPEUTICS HOLDINGS, INC. (RANI)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 3
  • 1 comments

Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer

Market reaction Comment Full text

PULTEGROUP INC/MI/ (PHM)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 3
  • 1 comments

PulteGroup to Launch New Explore by Del Webb Verona Community

Market reaction Comment Full text

4D MOLECULAR THERAPEUTICS, INC. (FDMT)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 4
  • 1 comments

4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital

Market reaction Comment Full text

OPTICAL CABLE CORP (OCC)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 4
  • 1 comments

OPTICAL CABLE CORPORATION JOINS RUSSELL MICROCAP® INDEX

Market reaction Comment Full text

4D MOLECULAR THERAPEUTICS, INC. (FDMT)

  • Business News
  • June 29, 2026, 12:00 UTC
  • 4
  • 1 comments

4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD

Market reaction Comment Full text
  • Previous
  • 4218
  • 4219
  • 4220
  • 4221
  • 4222
  • Next

Search

News categories

  • Technical Exchange News(14802)
  • Event(6229)
  • SEC News(399580)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243712)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin